Scientific platforms

Five technologies grounded in three foundational scientific principles.

Veredis™, Fusanix™, and Rasalis™ translate three foundational principles—matrix, signals, and cellular responsiveness—into a portfolio spanning multiple regenerative technologies.

01Regenerative Matrix Science

Veredis™

Advanced biological and synthetic matrix technologies designed to provide structural and biological support for tissue regeneration.

The Veredis™ franchise brings three related technologies under one enduring matrix-science identity: a minimally processed osteoinductive matrix, a proprietary matrix-reconditioning process, and a synthetic osteoconductive matrix. The platform is designed to expand with future biomaterials, scaffold technologies, and matrix-processing innovations.

  • Veredis™ Osteoinductive Matrix
  • Veredis™ Matrix Reconditioning Process
  • Veredis™ Conductive Matrix
  • Future biomaterial and scaffold technologies
02Regenerative Signaling Biology

Fusanix™

Technologies that direct tissue regeneration through biological signaling.

The first Fusanix™ program focuses on engineered recombinant BMP variants intended to enhance bone-forming capability while minimizing undesirable effects such as bone resorption and inflammation. Early in vitro findings support continued discovery work; detailed constructs and mechanisms remain confidential while the intellectual-property strategy develops.

  • Engineered recombinant BMP variants
  • Enhanced osteoinductive activity
  • Reduced undesirable biological effects
  • Future proteins, peptides, and signaling technologies
03Regenerative Reset Biology

Rasalis™

Technologies that restore tissues to a regenerative-competent state by re-establishing biological conditions that enable endogenous healing.

Cartilage regeneration is the first Rasalis™ application. In early tissue-culture studies, treated undifferentiated cells developed a cartilage phenotype and expressed specific chondrocytic markers. The treatment and proposed mechanism remain confidential pending intellectual-property protection.

  • Restoration of regenerative competence
  • Induction of cartilage phenotype in tissue culture
  • Expression of specific chondrocytic markers
  • Future expansion beyond a single tissue or anatomy

Strategic development

Explore a platform with Applied Regenerative Therapeutics.

We welcome selected conversations involving validation, co-development, manufacturing, licensing, and strategic investment.

Discuss a Collaboration